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Protocol and/or GCP deviations occur in many clinical
trials. There are clear definitions and reporting guide-
lines on serious breaches in Clinical Trials of Investiga-
tional Medicinal Products (CTIMPs)[1]. However there
is no such national guidance for non-CTIMPs. For any
trial design, there is little, if any, information on when
and for what type of incident it is appropriate to write a
file note or when a breach report is the appropriate
action. Should we consider whether an event that has
been recorded by a file note but then repeated becomes
a breach? There is also lack of clarity about the jargon
we (and others) use - violation, deviation, breach - do
they all mean the same or, if not, which is the most
appropriate terminology to use for what type of event?
This lack of clarity leads to confusion and inconsistency.
We will present incidents that we have been directly
involved in and discuss how we have handled these. We
will also discuss how we have developed our guidance on
recording file notes and breaches. This will include defini-
tions, information recorded, how decisions are made and
by whom and when oversight by sponsor is required.
Published: 29 November 2013
Reference




Cite this article as: McDonald et al.: File notes and breach reports: when
are they appropriate? Trials 2013 14(Suppl 1):P133.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
University of Aberdeen, Aberdeen, UK
McDonald et al. Trials 2013, 14(Suppl 1):P133
http://www.trialsjournal.com/content/14/S1/P133 TRIALS
© 2013 McDonald et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
